NO20055582D0 - Compositions and Methods comprising Gastrin Compounds - Google Patents

Compositions and Methods comprising Gastrin Compounds

Info

Publication number
NO20055582D0
NO20055582D0 NO20055582A NO20055582A NO20055582D0 NO 20055582 D0 NO20055582 D0 NO 20055582D0 NO 20055582 A NO20055582 A NO 20055582A NO 20055582 A NO20055582 A NO 20055582A NO 20055582 D0 NO20055582 D0 NO 20055582D0
Authority
NO
Norway
Prior art keywords
compositions
methods
gastrin compounds
gastrin
compounds
Prior art date
Application number
NO20055582A
Other languages
Norwegian (no)
Other versions
NO20055582L (en
Inventor
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en
Application filed by Waratah Pharmaceuticals Inc filed Critical Waratah Pharmaceuticals Inc
Publication of NO20055582D0 publication Critical patent/NO20055582D0/en
Publication of NO20055582L publication Critical patent/NO20055582L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20055582A 2003-05-27 2005-11-25 Compositions and Methods comprising Gastrin Compounds NO20055582L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/016660 WO2003100024A2 (en) 2002-05-24 2003-05-27 Treatment for diabetes
PCT/CA2004/000769 WO2004105780A2 (en) 2003-05-27 2004-05-27 Compositions comprising gastrin compounds and their use in diabetes

Publications (2)

Publication Number Publication Date
NO20055582D0 true NO20055582D0 (en) 2005-11-25
NO20055582L NO20055582L (en) 2006-02-27

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055582A NO20055582L (en) 2003-05-27 2005-11-25 Compositions and Methods comprising Gastrin Compounds

Country Status (11)

Country Link
EP (1) EP1648495A2 (en)
JP (1) JP2007513059A (en)
CN (1) CN1829528A (en)
AU (1) AU2004243541A1 (en)
BR (1) BRPI0410710A (en)
CA (1) CA2527186A1 (en)
MX (1) MXPA05012605A (en)
NO (1) NO20055582L (en)
PL (1) PL379145A1 (en)
RU (1) RU2005140518A (en)
WO (1) WO2004105780A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055152A2 (en) 2001-01-12 2002-07-18 Waratah Pharmaceuticals, Inc. Composition for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
CN1671407B (en) 2002-06-07 2010-05-26 瓦拉塔药品公司 Compositions and methods for treating diabetes
EP1837031B1 (en) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
US20090202494A1 (en) * 2004-01-30 2009-08-13 Antonio Cruz Combined use of glp-1 agonists and gastrin for regulating blood glucose levels
US20100256061A1 (en) * 2007-03-02 2010-10-07 Antonio Cruz Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
EP1466618B1 (en) * 1994-01-24 2009-06-03 The General Hospital Corporation Treatment for diabetes
WO2002055152A2 (en) * 2001-01-12 2002-07-18 Waratah Pharmaceuticals, Inc. Composition for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
EP2080521A1 (en) * 2002-10-22 2009-07-22 Waratah Pharmaceuticals, Inc. Gastrin compositions and formulations, and methods of use and preparation

Also Published As

Publication number Publication date
CN1829528A (en) 2006-09-06
BRPI0410710A (en) 2006-06-13
JP2007513059A (en) 2007-05-24
RU2005140518A (en) 2007-07-10
EP1648495A2 (en) 2006-04-26
WO2004105780A3 (en) 2005-01-20
MXPA05012605A (en) 2006-02-22
NO20055582L (en) 2006-02-27
PL379145A1 (en) 2006-07-24
AU2004243541A1 (en) 2004-12-09
WO2004105780A2 (en) 2004-12-09
CA2527186A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
NL301059I2 (en) Darvadstrocel
NO20055837D0 (en) Immunosuppressants and Compositions
IS8320A (en) N-substituted pyrazolyl-amidyl-benzimidazolyl
DK1592686T3 (en) Gyrase Inhibitors and Uses thereof
DE602004031845D1 (en) NG
NO20032220D0 (en) Löfteverktöy II and method for using the same
DE502004011955D1 (en) DOPPELKUPPLLUNGSGETRIEBE
NO20032883D0 (en) Bölgekraftverk
DE50311137D1 (en) ERIEBAUTEILE
DE602004018837D1 (en) PTIDASE-IV INHIBITORS
DE602004000356T8 (en) Connectors
SE0302091L (en) Implementation
IS8273A (en) New equipment
DK1601744T3 (en) ENGINEERING AND PROCEDURE
DE502004002085D1 (en) Multiple insertion
IS8489A (en) Transcriptors and their methods
FI20031741A (en) travolator
DE602004024235D1 (en) AMIDOACETONITRILDERIVATE
NO20055582D0 (en) Compositions and Methods comprising Gastrin Compounds
DE602004018799D1 (en) NG
ATE514681T1 (en) N-SUBSTITUTED PYRAZOLYLCARBOXANILIDES
NO20030752L (en) Bolgedempningsanordning
NO20032330L (en) Plug
DE502004002978D1 (en) N-biaryl
DE502004000518D1 (en) Mitgängergabelhubwagen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application